Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Clemmons
David L. Clemmons, Dunkirk, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20110132273 | Animal Cage And Method Of Assembly Thereof - The present invention relates to a method of forming an enclosure assembly without using tools or fasteners to complete the assembly. The method includes forming a base from a side support, front support, and a plurality of casters. A door assembly and back wall are coupled to the base by aligning a plurality of pegs therefrom with corresponding openings defined in the base. A plurality of protruding wires of a bottom wall are aligned and inserted into corresponding openings defined in the door assembly and back wall. In addition, a plurality of pegs that protrude from a side wall are inserted into a plurality of corresponding openings defined in the door assembly and back wall such that the side wall couples to the door assembly and back wall. The method also includes coupling a top wall to the door assembly, side wall, and back wall. A shelf assembly can be coupled to the side wall and/or back wall, and a ramp can be pivotably coupled to the shelf assembly. | 06-09-2011 |
David R. Clemmons, Chapel Hill, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20090280127 | MONOCLONAL ANTIBODIES FOR ENHANCING OR INHIBITING INSULIN-LIKE GROWTH FACTOR-I - The present invention provides αVβ3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same. | 11-12-2009 |
| 20100215640 | METHOD FOR INHIBITING CELLULAR ACTIVATION BY INSULIN-LIKE GROWTH FACTOR-1 - A method of inhibiting cellular activation by Insulin-like Growth Factor-1 (IGF-1) in a subject in need thereof (e.g., a subject afflicted with cancer, atherosclerosis, diabetic retinopathy or other disease) comprises administering an antagonist that inhibits the binding of IAP to SHPS-1 to the subject in an amount effective to inhibit cellular activation by IGF-1. Compounds and compositions for carrying out such methods are also described. | 08-26-2010 |
John Clemmons, Tampa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20090326394 | BLOOD PRESSURE CUFF APPARATUS AND SYSTEM - A pressure cuff is disclosed herein. The pressure cuff includes a sleeve and a cuff bladder. The cuff bladder defines a bladder length of 9.2+/−2.1 centimeters and a bladder width of 24.6+/−4.2 centimeters. The bladder length and bladder width dimensions provide precise non-invasive blood pressure measurements when the pressure cuff is applied to a forearm having a circumference in the range of 27 to 37 centimeters. | 12-31-2009 |
John P. Clemmons, Tampa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20090062663 | NON-INVASIVE BLOOD PRESSURE MONITOR APPARATUS AND SYSTEM - A non-invasive blood pressure monitoring system is disclosed herein. The non-invasive blood pressure monitoring system includes a pressure cuff comprising a resistive portion and a conductive portion aligned with the resistive portion. The non-invasive blood pressure monitoring system also includes a controller operatively connected to the pressure cuff. The controller is adapted to estimate the circumference of the pressure cuff based on the position of the conductive portion relative to the resistive portion. | 03-05-2009 |
Julie Clemmons, Raleigh, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20090020243 | Use of Cyclodextrins for Reducing Deposits During Paper Production - The present invention relates to a method for preventing or reducing deposits in pulp and paper making processes by including a cyclodextrin during or after pulp formation in an amount effective for preventing or reducing the deposits. Optionally the cyclodextrin comprising the deposit is subsequently separated from the pulp. | 01-22-2009 |
Paul Clemmons, Canyon, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110099063 | My Life Cost (MLC) Systems and Methods - According to an exemplary embodiment, the My Life Cost system and method includes a budgeting and business marketing software application that detects, tracts, stores and analyzes financial transactions of a member to provide financial incentives and influence consumer spending. The My Life Cost system and method monitor the amount of money, credit or budgeted category that a member has available to spend on specific merchandise and services. In further exemplary embodiments, the My Life Cost system and method includes an interactive financial coach that helps members make informed spending choices. Still according to other exemplary examples, the My Life Cost method and system provides marketing services to qualified businesses on a commission basis without any required upfront costs or any additional advertising fees. My Life Cost earns a commission from a participating merchant or business when a sale is made by one of its member. In further exemplary embodiments, the My Life Cost system and method includes on-line reports or notifications to a communications device that may be customized for each member and for each participating merchant or business. | 04-28-2011 |